BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-2906 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-2906\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07280936-11102@assetmemo.bio
DTSTAMP:20261121T005411Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:SHR-2906: Phase 1 readout est. (NCT07280936)
DESCRIPTION:SHR-2906\, phase 1\, Obesity.\nStudy: A Study of SHR-2906 Injec
 tion in Healthy Subjects With a Single Dose and in Obese Patients With Mul
 tiple Doses\nEstimated primary completion: December 2026. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/shr-2906#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT07280936
URL:https://assetmemo.bio/drug/shr-2906#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
